BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Febbo JA, Gaddikeri RS, Shah PN. Stereotactic Body Radiation Therapy for Early-Stage Non–Small Cell Lung Cancer: A Primer for Radiologists. RadioGraphics 2018;38:1312-36. [DOI: 10.1148/rg.2018170155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Al-umairi R, Tarique U, Moineddin R, Jimenez-juan L, Kha LC, Cheung P, Oikonomou A. CT patterns and serial CT Changes in lung Cancer patients post stereotactic body radiotherapy (SBRT). Cancer Imaging 2022;22. [DOI: 10.1186/s40644-022-00491-1] [Reference Citation Analysis]
2 Faroni L, Collie L, Gabrielli F, Baldotto C, Moraes F. Role of Stereotactic Radiation Therapy in Operable and Inoperable Early-Stage Non-small Cell Lung Cancer. Curr Treat Options Oncol 2022. [PMID: 35969313 DOI: 10.1007/s11864-022-01002-x] [Reference Citation Analysis]
3 Ahmed N, Kidane B, Wang L, Nugent Z, Moldovan N, McElrea A, Shariati-Ievari S, Qing G, Tan L, Buduhan G, Srinathan SK, Meyers R, Aliani M. Metabolic Alterations in Sputum and Exhaled Breath Condensate of Early Stage Non-Small Cell Lung Cancer Patients After Surgical Resection: A Pilot Study. Front Oncol 2022;12:874964. [PMID: 35719971 DOI: 10.3389/fonc.2022.874964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Habermann FOJ, Schmitt D, Failing T, Fischer J, Ziegler DA, Fischer LA, Alt NJ, Muster J, Donath S, Hille A, Schirmer MA, Guhlich M, El Shafie RA, Rieken S, Leu M, Dröge LH. Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes. Current Oncology 2022;29:1080-92. [DOI: 10.3390/curroncol29020092] [Reference Citation Analysis]
5 Bousabarah K, Blanck O, Temming S, Wilhelm ML, Hoevels M, Baus WW, Ruess D, Visser-Vandewalle V, Ruge MI, Treuer H, Kocher M. Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions. Radiat Oncol 2021;16:74. [PMID: 33863358 DOI: 10.1186/s13014-021-01805-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Amin SA, Alam M, Baine MJ, Meza JL, Bennion NR, Zhang C, Rahman I, Lin C. The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer. Radiother Oncol 2021;155:254-60. [PMID: 33317997 DOI: 10.1016/j.radonc.2020.10.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Christie JR, Lang P, Zelko LM, Palma DA, Abdelrazek M, Mattonen SA. Artificial Intelligence in Lung Cancer: Bridging the Gap Between Computational Power and Clinical Decision-Making. Can Assoc Radiol J. 2021;72:86-97. [PMID: 32735493 DOI: 10.1177/0846537120941434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chassagnon G, Martini K, Giraud P, Revel MP. Radiological assessment after stereotactic body radiation of lung tumours. Cancer Radiother 2020;24:379-87. [PMID: 32534799 DOI: 10.1016/j.canrad.2020.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Kim TH, Woo S, Halpenny DF, Kim YJ, Yoon SH, Suh CH. Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis. Eur J Radiol 2020;127:108978. [PMID: 32298960 DOI: 10.1016/j.ejrad.2020.108978] [Cited by in F6Publishing: 3] [Reference Citation Analysis]